Am J Physiol Cell Physiol AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol (July 5, 2006). doi:10.1152/ajpcell.00552.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/6/C1336    most recent
00552.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, S.
Right arrow Articles by Jiang, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, S.
Right arrow Articles by Jiang, B.
Submitted on October 28, 2005
Accepted on July 3, 2006

Ribosomal S6 kinase-1 modulates interleukin-1{beta}-induced persistent activation of NF-{kappa}B through phosphorylation of I-{kappa}B{beta}

Shanqin Xu1, Hossein Bayat1, Xiuyun Hou1, and Bingbing Jiang1*

1 Vascular Biology Unit, Whitaker Cardiovascular Institute, Department of Medicine, Boston University School of Medicine, Boston, United States

* To whom correspondence should be addressed. E-mail: bjiang{at}bu.edu.

Activation of NF-{kappa}B requires the phosphorylation and degradation of its associated inhibitory proteins I-{kappa}B. Previously we reported that the extracellular signal-regulated kinase (ERK) is required for interleukin-1{beta} to induce persistent activation of NF-{kappa}B in cultured rat vascular smooth muscle cells (VSMCs). The present study examined the mechanism by which the ERK signaling cascade modulates the duration of NF-{kappa}B activation. In cultured rat VSMCs, interleukin-1{beta} activated ERK and induced degradation of both I-{kappa}B{alpha} and I-{kappa}B{beta}, which was associated with nuclear translocation of both ribosomal S6 kinase (RSK)-1 and NF-{kappa}B p65. RSK1, a downstream kinase of ERK, was associated with an I-{kappa}B{beta}/NF-{kappa}B complex, which was independent of the phosphorylation status of RSK1. Treatment of VSMCs with interleukin-1{beta} decreased I-{kappa}B{beta} in the RSK1/I-{kappa}B{beta}/NF-{kappa}B complex, an effect that was attenuated by inhibition of ERK activation. Knockdown of RSK1 by small interference RNA attenuated the IL-1{beta}-induced I-{kappa}B{beta} decrease without influencing ether ERK phosphorylation or the earlier I-{kappa}B{alpha} degradation. By using recombinant wild type and mutant I-{kappa}B{beta} proteins, both active ERK2 and RSK1 were found to directly phosphorylate I-{kappa}B{beta}, but only active RSK1 phosphorylated I-{kappa}B{beta} on Ser19 and Ser23, two sites known to mediate the subsequent ubiquitination and degradation. In conclusion, in the ERK signaling cascade, RSK1 is a key component that directly phosphorylates I-{kappa}B{beta} and contributes to the persistent activation of NF-{kappa}B by IL-1{beta}.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
T. M. Lindstrom, A. R. Mohan, M. R. Johnson, and P. R. Bennett
Histone Deacetylase Inhibitors Exert Time-Dependent Effects on Nuclear Factor-{kappa}B but Consistently Suppress the Expression of Proinflammatory Genes in Human Myometrial Cells
Mol. Pharmacol., July 1, 2008; 74(1): 109 - 121.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.